Categories AlphaGraphs, Earnings, Technology

Oracle (ORCL) Earnings: Q1 profit rises, tops Street view on strong revenue growth

Software giant Oracle Corporation (NYSE: ORCL) reported strong growth in the first-quarter profit and revenues. Earnings topped Wall Street’s prediction, while the top-line slightly missed.

Oracle Q1 2022 earnings infographic

At $9.7 billion, revenues were up 4% year-over-year in the first three months of fiscal 2022. But the top-line came in below the market’s projection.

Adjusted earnings moved up to $1.03 per share from $0.93 per share in the first quarter of 2021 and topped the Street view. Net income, including one-off items, was $2.5 billion or $0.86 per share, compared to $2.3 billion or $0.72 per share last year.

Read management/analysts’ comments on Oracle’s Q1 results

Oracle’s shares closed Monday’s regular trading lower and continued to decline during the extended session.

Prior Performance

  • Oracle Q4 2021 earnings infographic
  • Oracle Announces Fiscal 2021 Second Quarter Financial Results


Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock


Most Popular

WMT Earnings: All you need to know about Walmart’s Q2 2023 earnings results

Walmart Inc. (NYSE: WMT) reported second quarter 2023 earnings results today. Total revenue increased 8.4% year-over-year to $152.9 billion. Revenues grew 9.1% in constant currency. Consolidated net income attributable to

Rivian (RIVN) reaffirms production goals. Will it be a smooth ride?

The evolution of the electric vehicle industry accelerated in recent years even as innovations in battery technology and affordability brought EVs into the mainstream. Encouraged by the success of market

Pfizer (PFE): A look at the headwinds and tailwinds this pharma giant faces in the near term

Shares of Pfizer Inc. (NYSE: PFE) were down on Monday. The stock has dropped 15% year-to-date and there is a mixed sentiment surrounding the company’s growth prospects. Pfizer has benefited

Add Comment
Viewing Highlight